E-DRUG: Good or bad clinical practice? (cont)
--------------------------------------------
Dear E-drug users,
I feel Kirsten has correctly opened a topic for discussion. The present
clinical trials are they good or bad? At least the Norwegian effort has
focused on the safety and welfare of the participating patients.
Clinical trials are based on profession perspectives. The assessment of
efficacy and safety of any drug or medical device is the main objective
of existing methods adopted in clinical trials. In most industrialized
countries the consequence for economy, environment and health have been
closely monitored.
But a lot of studies (Hansen EH. Technology
Assessment in a User Perspective - Experiences with Drug Technology.
International Journal of Technology Assessment in Health Care 1992;
8(1):150-165) have shown that clinical trials do not perfectly address
the problems which appear after the product have been used.
Thus an effective product produced with highest quality assurance system
prescribed by a qualified prescriber according to the best norms set by
the clinical trial do not fullfill the user perspective and is not used
properly in the social settings.
Now, could it be possible to think more in social and user perspective
while designing a clinical trial for drugs?
Shiba Karkee
DS Co-ordinator
The Britain Nepal Medical Trust.
Nepal
Email: dspbnmt@mos.com.np [added manually, WB]
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.